miR-145 levels are reduced in tumor samples and cell lines with respect to normal tissue in non-small cell lung cancer and inversely correlated with those of SMAD3, one of the key transcription factors involved in TGF-β responses and later characterized as a direct miR-145 target [75]. The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.